Literature DB >> 29407076

The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis.

Philip Brainin1, Daria Frestad2, Eva Prescott3.   

Abstract

AIMS: Coronary vascular dysfunction is linked with poor cardiovascular prognosis in patients without obstructive coronary artery disease (CAD) but a critical appraisal of the literature is lacking. METHODS AND
RESULTS: We performed a systematic review and meta-analysis to quantify the cardiovascular risk associated with endothelial dependent and non-endothelial dependent coronary vascular dysfunction in patients with normal or non-obstructive CAD (epicardial stenosis <50%). Prospective cohort studies that reported coronary vascular dysfunction at baseline and cardiovascular outcomes at follow-up were included. We identified 52 papers of which 26 were included in the meta-analyses. Study populations included stable angina (n=15), heart failure (n=4), diabetes (n=2), hypertrophic obstructive cardiomyopathy (n=2), chronic kidney disease, aortic stenosis and left atrial enlargement (each n=1): RR estimates were similar in patients with stable angina and other patient groups. For epicardial endothelial dependent dysfunction (six studies, 243 events in 1192 patients) the summarized RR was 2.38 (95% confidence intervals (95% CI) 1.74-3.25), for non-endothelial dependent dysfunction assessed as coronary flow velocity reserve (CFVR) by echocardiography (10 studies, 428 events in 5134 patients) RR was 4.58 (95% CI 3.58-5.87) and for coronary flow reserve (CFR) by PET (10 studies, 538 events in 3687 patients) RR was 2.44 (95% CI 1.80-3.30). However, RR estimates were robust in a series of sensitivity analyses.
CONCLUSION: The presence of coronary vascular dysfunction in patients with normal or non-obstructive CAD predicts adverse cardiovascular outcome. Multicentre studies and uniform guidelines for assessing coronary vascular dysfunction are encouraged.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coronary flow reserve; Coronary flow velocity reserve; Coronary heart disease; Coronary vascular dysfunction; Epicardial endothelial dependent dysfunction; Non-endothelial dependent dysfunction

Mesh:

Year:  2018        PMID: 29407076     DOI: 10.1016/j.ijcard.2017.10.052

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  25 in total

1.  An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

Authors:  Vijay Kunadian; Alaide Chieffo; Paolo G Camici; Colin Berry; Javier Escaned; Angela H E M Maas; Eva Prescott; Nicole Karam; Yolande Appelman; Chiara Fraccaro; Gill Louise Buchanan; Stephane Manzo-Silberman; Rasha Al-Lamee; Evelyn Regar; Alexandra Lansky; J Dawn Abbott; Lina Badimon; Dirk J Duncker; Roxana Mehran; Davide Capodanno; Andreas Baumbach
Journal:  Eur Heart J       Date:  2020-10-01       Impact factor: 29.983

Review 2.  Nuclear Cardiology in Women and Underrepresented Minority Populations.

Authors:  Renee P Bullock-Palmer; Amalia Peix; Niti R Aggarwal
Journal:  Curr Cardiol Rep       Date:  2022-03-09       Impact factor: 2.931

Review 3.  Stable Ischemic Heart Disease in Women.

Authors:  Kelly M T Schmidt; John Nan; Dawn C Scantlebury; Niti R Aggarwal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

Review 4.  Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.

Authors:  Daria Frestad Bechsgaard; Eva Prescott
Journal:  Curr Atheroscler Rep       Date:  2021-07-16       Impact factor: 5.113

5.  Evaluation of computed tomography myocardial perfusion in women with angina and no obstructive coronary artery disease.

Authors:  Daria Frestad Bechsgaard; Ida Gustafsson; Marie Mide Michelsen; Naja Dam Mygind; Kristoffer Flintholm Raft; Jesper James Linde; Klaus Fuglsang Kofoed; Fay Yu-Huei Lin; James K Min; Eva Prescott; Jens Dahlgaard Hove
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-01       Impact factor: 2.357

Review 6.  Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance.

Authors:  Tharusha Gunawardena; Ioannis Merinopoulos; Upul Wickramarachchi; Vassilios Vassiliou; Simon Eccleshall
Journal:  Curr Cardiol Rev       Date:  2021

Review 7.  Advances in translational imaging of the microcirculation.

Authors:  Marie Guerraty; Akanksha Bhargava; Janaka Senarathna; Asher A Mendelson; Arvind P Pathak
Journal:  Microcirculation       Date:  2021-03-13       Impact factor: 2.679

8.  Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.

Authors:  Seung Hun Lee; Doosup Shin; Joo Myung Lee; Tim P van de Hoef; David Hong; Ki Hong Choi; Doyeon Hwang; Coen K M Boerhout; Guus A de Waard; Ji-Hyun Jung; Hernan Mejia-Renteria; Masahiro Hoshino; Mauro Echavarria-Pinto; Martijn Meuwissen; Hitoshi Matsuo; Maribel Madera-Cambero; Ashkan Eftekhari; Mohamed A Effat; Tadashi Murai; Koen Marques; Joon-Hyung Doh; Evald H Christiansen; Rupak Banerjee; Hyun Kuk Kim; Chang-Wook Nam; Giampaolo Niccoli; Masafumi Nakayama; Nobuhiro Tanaka; Eun-Seok Shin; Steven A J Chamuleau; Niels van Royen; Paul Knaapen; Bon Kwon Koo; Tsunekazu Kakuta; Javier Escaned; Jan J Piek
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

Review 9.  A pathophysiological compass to personalize antianginal drug treatment.

Authors:  Edoardo Bertero; Gerd Heusch; Thomas Münzel; Christoph Maack
Journal:  Nat Rev Cardiol       Date:  2021-07-07       Impact factor: 32.419

Review 10.  Angiogenic CD34 Stem Cell Therapy in Coronary Microvascular Repair-A Systematic Review.

Authors:  Balaj Rai; Janki Shukla; Timothy D Henry; Odayme Quesada
Journal:  Cells       Date:  2021-05-08       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.